COVID-19 and infectious diseases have been included in strategic development goals
(SDG) of United Nations (UN). Severe form of COVID-19 has been described as an …

Plasma concentrations of extracellular vesicles (EVs) originating from cells involved in
COVID-19-associated coagulopathy (CAC), their longitudinal trend and association with …

COVID-19 infection caused by the novel severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) has resulted in a global pandemic with the number of deaths growing …

Severe COVID-19 infections present with cytokine storms, hypercoagulation, and acute
respiratory distress syndrome, with extracellular vesicles (EVs) being involved in …

Endotheliopathy is suggested to be an important feature of COVID-19 in hospitalized
patients. To determine whether endotheliopathy is involved in COVID-19-associated …

Abstract Coronavirus disease‐2019 (COVID‐19), caused by the novel severe acute
respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), has lead to a global pandemic with a …

Beside the commonly described pulmonary expression of the coronavirus disease 2019
(COVID-19), major vascular events have been reported. The objective of this study was to …

New investigation results point to the potential participation of extracellular vesicles (EVs) in
the pathogenesis of coronavirus infection, its progression, and mechanisms of the therapy …

Abstract COVID‐19 is heterogeneous; therefore, it is crucial to identify early biomarkers for
adverse outcomes. Extracellular vesicles (EV) are involved in the pathophysiology of COVID …

In severe SARS-CoV-2 infections, emerging data including recent histopathological studies
have emphasized the crucial role of endothelial cells (ECs) in vascular dysfunction …